Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1

Infection and Immunity

Volumn 65, Issue 9, 1997, Pages 3571-3576

  Qadri, Firdausi ^a,d   Wennerås, Christine ^b   Albert, M John ^a   Hossain, Jaber ^a   Mannoor, Kaiissar ^a   Begum, Yasmin Ara ^a   Mohi, Golam ^a   Salam, Mohammad Abdus ^a   Sack, R Bradley ^c   Svennerholm, Ann Mari ^b  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d ICDDRB Laboratory Sciences Division   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; CHOLERA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; VIBRIO CHOLERAE;

EID: 0030931383     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.9.3571-3576.1997     Document Type: Article

References (42)

1. Albert, M. J. 1996. Epidemiology and molecular biology of V. cholerae O139 Bengal. Indian J. Med. Res. 104:14-27.
2. Albert, M. J., K. Alam, M. Ansaruzzaman, F. Qadri, and R. B. Sack. 1994. Lack of cross-protection against diarrhea due to Vibrio cholerae O139 synonym Bengal after oral immunization of rabbits with V. cholerae O1 vaccine strain, CVD103-HgR. J. Infect. Dis. 169:230-231.
3. Albert, M. J., M. Ansaruzzaman, T. Shimada, A. Rahman, N. A. Bhuiyan, S. Nahar, F. Qadri, and M. S. Islam. 1995. Characterization of Aeromonas trota strains that cross-react with Vibrio cholerae O139 Bengal. J. Clin. Microbiol. 33:3119-3123.
4. Albert, M. J., A. K. Siddique, M. S. Islam, A. S. G. Faruque, M. Ansaruzzaman, S. M. Faruque, and R. B. Sack. 1993. Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet 341:704.
5. Benenson, A. S., M. R. Islam, and W. B. Greenough III. 1964. Rapid identification of Vibrio cholerae by dark field microscopy. Bull. W.H.O. 30:827-831.
6. Coster, T. S., K. P. Killeen, M. K. Waldor, D. T. Beattie, D. R. Spriggs, J. R. Kener, A. Trofa, J. C. Sadoff, J. J. Mekalanos, and D. N. Taylor. 1995. Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet 345:949-952.
7. Cox, A. D., and M. B. Perry. 1996. Structural analysis of the O-antigen core region of the lipopolysaccharide from Vibrio cholerae O139. Carbohydr. Res. 290:59-65.
8. Czerkinsky, C., Z. Moldoveanu, J. Mestecky, L. A. Nilsson, and O. Ouchterlony. 1988. A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J. Immunol. Methods 115:31-37.
9. Czerkinsky, C., S. J. Prince, S. M. Michalek, S. Jackson, M. W. Russell, Z. Moldoveanu, J. R. McGhee, and J. Mestecky. 1987. IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc. Natl. Acad. Sci. USA 84:2449-2453.
10. Czerkinsky, C., A.-M. Svennerholm, and J. Holmgren. 1993. Induction and assessment of immunity and enteromucosal surfaces in humans: implications for vaccine development. Clin. Infect. Dis. 16:S106-S116.
11. Favre, D., S. J. Cryz, Jr., and J.-R. Viret. 1996. Construction and characterization of potential live oral carrier-based vaccine against Vibrio cholerae O139. Infect. Immun. 64:3565-3570.
12. Glass, R. I., A.-M. Svennerholm, M. K. Khan, S. Huda, M. I. Huq, and J. Holmgren. 1985. Seroepidemiological studies of E1 Tor cholera in Bangladesh: association of serum antibody levels with protection. J. Infect. Dis. 151:236-242.
13. Hisatsune, K., R. S. Kondo, Y. Isshiki, T. Iguchi, Y. Kawamata, and T. Shimada. 1993. O-antigenic lipopolysaccharide of Vibrio cholerae O139 Bengal, a new epidemic strain for recent cholera in the Indian subcontinent. Biochem. Biophys. Res. Commun. 196:1309-1315.
14. Jertborn, M., A.-M. Svennerholm, and J. Holmgren. 1986. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J. Clin. Microbiol. 24:203-209.
15. --O1/O139 whole cell cholera vaccine. Vaccine 14:1459-1465.
16. Johnson, J. A., C. A. Salles, P. Panigrahi, M. J. Albert, A. C. Wright, R. J. Johnson, and J. G. Morris, Jr. 1994. Vibrio cholerae O139 synonym Bengal is closely related to Vibrio cholerae O139 E1 Tor but has important differences. Infect. Immun. 62:2108-2110.
17. Jonson, G., J. Osek, A.-M. Svennerholm, and J. Holmgren. 1996. Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development. Infect. Immun. 64:3778-3785.
18. Kantele, A., H. Arvilommi, and I. Jokinen. 1986. Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. J. Infect. Dis. 153:1126-1131.
19. Kantele, A. M., T. Takanen, and A. Arvilommi. 1988. Immune response to acute diarrhea seen as circulating antibody secreting cells. J. Infect. Dis. 158:1011-1016.
20. Li, A., A. Karnell, P. T. Huan, P. C. Cam, N. B. Minh, L. N. Tram, N. P. Quy, D. D. Trach, K. Karlsson, G. Lindberg, and A. A. Lindberg. 1993. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL 124 in adult Vietnamese volunteers. Vaccine 11:180-189.
21. Losonsky, G. A., C. O. Tacket, S. S. Wasserman, J. B. Kaper, and M. M. Levine. 1993. Secondary Vibrio cholerae specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection. Infect. Immun. 61:729-33.
22. McDermott, M. R., and J. Bienestock. 1979. Evidence for a common mucosal immune system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122:1892-1892.
23. Monsur, K. A. 1961. A highly selective gelatin-taurocholate tellurite medium for the isolation of Vibrio cholerae. Trans. R. Soc. Trop. Med. Hyg. 55:440-442.
24. Morris, J. G., Jr., G. H. Losonsky, J. A. Johnson, C. O. Tacket, J. P. Nataro, P. Panigrahi, and M. M. Levine. 1995. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers. J. Infect. Dis. 171:903-908.
25. Orr, N., G. Robin, G. Lowell, and D. Cohen. 1992. Presence of specific immunoglohulin A-secreting cells in peripheral blood after natural infection with Shigella sonnei. J. Clin. Microbiol. 30:2165-2168.
26. Panigrahi, P., S. Srinivas, and J. G. Morris, Jr. 1992. In vivo modulation of non-O1 Vibrio cholerae virulence, abstr. 616, p. 213. In Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
27. Qadri, F., T. Azim, A. Chowdhury, J. Hossain, R. B. Sack, and M. J. Albert. 1994. Production, characterization and application of monoclonal antibodies to Vibrio cholerae O139 synonym Bengal. Clin. Diagn. Lab. Immunol. 1:51-54.
28. Qadri, F., S. Haq, S. A. Hossain, I. Ciznar, and S. Tzipori. 1991. The association of haemagglutination and adhesion with lipopolysaccharide of Shigella dysenteriae serotype 1. J. Med. Microbiol. 34:259-264.
29. Qadri, F., G. Jonson, Y. A. Begum, C. Wenneras, M. J. Albert, M. A. Salam, and A.-M. Svennerholm. 1997. Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O139. Clin. Diagn. Lab. Immunol. 4:429-434.
30. Qadri, F., G. Mohi, J. Hossain, T. Azim, A. M. Khan, M. A. Salam, R. B. Sack, M. J. Albert, and A.-M. Svennerholm. 1995. Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin. Diagn. Lab. Immunol. 2:685-688.
31. Quiding, M., I. Nordstrom, A. Kilanda, G. Andersson, L. A. Hanson, J. Holmgren, and C. Czerkinsky. 1991. Intestinal immune response in humans. J. Clin. Invest. 88:143-148.
32. Rahman, M., D. A. Sack, S. Mahmood, and A. Hossain. 1987. Rapid diagnosis of cholera by coagglutination test using 4-h fecal enrichment cultures. J. Clin. Microbiol. 25:2204-2206.
33. Raqib, R., S. Tzipori, M. Islam, and A. A. Lindberg. 1993. Immune response to Shigella dysenteriae 1 and Shigella flexneri lipopolysaccharide and polysaccharide antigens in Bangladeshi patients with shigellosis. Serodiagn. Immunother. Infect. Dis. 1:37-45.
34. Sanchez, J., and J. Holmgren. 1989. Recombinant system for over-expression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc. Natl. Acad. Sci. USA 86:481-485.
35. Svennerholm, A.-M., J. Holmgren, R. Black, M. Levine, and M. Merson. 1983. Serologic differentiation between antitoxic response to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J. Infect. Dis. 147:514-521.
36. Svennerholm, A.-M., M. Wikström, M. Lindblad, and J. Holmgren. 1986. Monoclonal antibodies against Escherichia coli heat-stable toxin (ST) and their use in a diagnostic ST ganglioside GM1-enzyme-linked immunological assay. J. Clin. Microbiol. 24:585-590.
37. Waldor, M. K., R. Colwell, and J. J. Mekalanos. 1994. The Vibrio cholerae O139 serogroup antigen includes capsular and lipopolysaccharide virulence determinants. Proc. Natl. Acad. Sci. USA 91:11388-11392.
38. Weintrauh, A., G. Widmalm, P.-E. Jansson, M. Hansson, K. Hultenby, and M. J. Albert. 1994. Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence. Microb. Pathog. 16:235-241.
39. Wenneras, C., A.-M. Svennerholm, A.-C. Ahren, and C. Czerkinsky. 1992. Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine. Infect. Immun. 60:2605-2611.
40. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides: extraction with phenol-water and further application of the procedure. Methods Carbohydr. Chem. 5:83-41.
41. World Health Organization. 1987. Programme for control of diarrhoeal diseases, p. 9-20. In Manual for laboratory investigations of acute enteric infections. CDD/83.3, revision 1. World Health Organization, Geneva, Switzerland.
42. World Health Organization. 1990. Manual for the treatment of diarrhoea: for use by physicians and other senior healthworkers. WHO/CDD/SER/80-2, revision 2. World Health Organization, Geneva, Switzerland.